title: Disease activity-guided TNF inhibitor dose reduction was noninferior to continuing TNF inhibitors for RA flares.
authors.forename: Francisco
authors.initials: F
authors.lastname: Ramirez-Lafita
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D005528:Foot / Q000000981:diagnostic imaging*; D006225:Hand / Q000000981:diagnostic imaging*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D008297:Male; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor